{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_14", "document_index": 84, "latency_s": 0.829843700004858, "prompt_toks": 6301, "completion_toks": 75, "relevance_score": 6.312651e-08}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    Legal status\n\nInternationally, cannabidiol is not scheduled under the Convention on Psychotropic Substances or any other UN drug treaty.\n\nAustralia: Cannabidiol (in preparations for therapeutic use containing 2 per cent or less of other cannabinoids found in cannabis) was placed in Schedule 4 as a \"Prescription Only Medicine OR Prescription Animal Remedy\" in 2015. It was previously listed in Schedule 9 as a prohibited substance.[31]\n\nCanada: Cannabidiol is specifically listed in the Schedule II Controlled Drugs and Substances Act. However, in 2016 Canada’s \"Access to Cannabis for Medical Purposes Regulations\" came into effect. These regulations improve access to cannabis used for medicinal purposes, including CBD.[32]\n\nHong Kong: Illegal in Hong Kong since 1st February 2023, punishable by 7 years imprisonment.[33]\n\n\n                    Context: \n                    This section provides an overview of the international and national legal statuses of cannabidiol (CBD), detailing its scheduling and legal restrictions in various countries. It highlights regions where CBD is legal, regulated, or illegal, and specifies recent changes in jurisdictions like Australia, Canada, and Hong Kong. This information is crucial for understanding the legal considerations associated with CBD use and distribution worldwide.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_16", "document_index": 84, "latency_s": 0.7780542999971658, "prompt_toks": 6422, "completion_toks": 80, "relevance_score": 6.312651e-08}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    United States: Cannabidiol is legal under the 2018 Farm Bill[37]. The rest of the cannabis plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.[citation needed]\n\nExternal links\n\nCannabidiol (Wikipedia)\n\nCannabidiol (Isomer Design)\n\nCannabidiol (Drugs-Forum)\n\nProject CBD\n\nLiterature\n\nMechoulam, R., Peters, M., Murillo-Rodríguez, E., & Hanuš, L.O. (2007). Cannabidiol--recent advances. Chemistry & Biodiversity, 4 8, 1678-92.\n\nMechoulam, R., Parker, L. A., & Gallily, R. (2002). Cannabidiol: an overview of some pharmacological aspects. The Journal of Clinical Pharmacology, 42(S1).\n\nDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., ... & Martinez‐Orgado, J. (2014). Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791-802. https://doi.org/0.1111/epi.12631\n\nReferences\n\n\n                    Context: \n                    This chunk provides information on the legal status of cannabidiol in the United States, highlighting its legality under the 2018 Farm Bill and its classification under Schedule I of the Controlled Substances Act. It also includes external links and key literature references relevant to cannabidiol research and regulation, complementing the overall focus on CBD's effects, safety, and legal considerations within the full document.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Psilocybin & Psilocin Vault : Timeline", "description": "A timeline of events in the history of psilocybin & psilocin", "language": "No language found.", "url": "https://www.erowid.org/chemicals/psilocybin/psilocybin_timeline.php", "drug": "Psilocybin", "cid": 10624, "substance": "psilocybin", "category": "CHEMICALS", "erowid_column": "History", "char_count": 9960, "word_count": 1440, "doc_id": "doc_227", "num_chunks": 13, "chunk_id": "227::chunk_8", "document_index": 227, "latency_s": 0.68761789999553, "prompt_toks": 3008, "completion_toks": 67, "relevance_score": 3.769456e-08}, "content": "Drug: Psilocybin | cid: 10624\nSource: erowid | Source description: A timeline of events in the history of psilocybin & psilocin\nErowid name: psilocybin\nCategory: CHEMICALS\nField: History\n\n                    Text: \n                    of consciousness as we know it.\" Note: \"The Corporation\" in the title of the article is Harvard. Oct 24, 1968 Possession of Psilocybin & Psilocin are banned federally in the U.S. after the passage of the Staggers-Dodd Bill (Public Law 90-639) which amended the Food, Drug, and Cosmetic Act. Oct 27, 1970 The Comprehensive Drug Abuse Prevention and Control Act is passed.  Part II of this is the Controlled Substance Act (CSA) which defines a scheduling system for drugs.  It places most of the known hallucinogens (LSD, psilocybin, psilocin, mescaline, peyote, cannabis, & MDA) in Schedule I.  It places coca, cocaine and injectable methamphetamine in Schedule II.  Other amphetamines and stimulants, including non-injectable methamphetamine are placed in Schedule III. 1960-1977 Psilocybin is studied as a psychotherapeutic medicine through the 1960s and 1970s.  FDA approved research with humans ends in 1977, not to be continued until the late 1990s. Late 1990's Research with psilocybin begins\n\n\n                    Context: \n                    This chunk covers the legal history and regulatory classification of psilocybin and other hallucinogens in the United States from the late 1960s to the late 1990s, including key legislation, scheduling, and research suppression, providing important context for understanding the drug's legal status and research trajectory discussed in the full webpage.\n                "}
